This site is intended for healthcare professionals only

In association with the Cardiorenal Forum

Articles

  • EMPA-VISION: Cardiac energy in people with heart failure taking empagliflozin

  • Chronic kidney disease and incident heart failure: insights from the Atherosclerosis Risk in Communities study

  • Optimising heart failure treatment for patients on peritoneal dialysis

    Optimising heart failure treatment for patients on peritoneal dialysis

  • Sacubitril/valsartan in peritoneal dialysis patients

    Sacubitril/valsartan in peritoneal dialysis patients

  • MyTEMP trial: Is this the end of “cooled dialysis”?

  • MyTEMP trial: Personalised cooler dialysate or standard for maintenance haemodialysis

    MyTEMP trial: Personalised cooler dialysate or standard for maintenance haemodialysis

  • Hypoxia-inducible factor prolyl- hydroxylase inhibitors for anaemia in patients with chronic kidney disease: Analysis of adverse events

    Hypoxia-inducible factor prolyl- hydroxylase inhibitors for anaemia in patients with chronic kidney disease: Analysis of adverse events

alt

For the latest news and articles
Sign up to Renal Review newsletters

Subscribe